Ukjent sin avatar

Respiratory weakness in patients with chronic neck pain.

Studie som nevner at alle med kroniske nakkeplager også har svake pustemuskler, og at pusten kan bidra til å opprettholde smertene. Spesielt ved svak utpust (MEP – maximal expiratory pressure) er det sammenheng med nakkesmerter. Kunne trengt hele denne studien.

http://www.ncbi.nlm.nih.gov/pubmed/23199797

Neck muscle strength (r > 0.5), kinesiophobia (r < -0.3) and catastrophizing (r < -0.3) were significantly associated with maximal mouth pressures (P < 0.05), whereas MEP was additionally negatively correlated with neck pain and disability (r < -0.3, P < 0.05).

It can be concluded that patients with chronic neck pain present weakness of their respiratory muscles. This weakness seems to be a result of the impaired global and local muscle system of neck pain patients, and psychological states also appear to have an additional contribution. Clinicians are advised to consider the respiratory system of patients with chronic neck pain during their usual assessment and appropriately address their treatment.

Ukjent sin avatar

Spectrum of gluten-related disorders: consensus on new nomenclature and classification

Oppdatert forhold til ikke-cøliakisk glutenintoleranse fra 14 eksperter i USA.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292448/

This review will summarize our current knowledge about the three main forms of gluten reactions: allergic (wheat allergy), autoimmune (celiac disease, dermatitis herpetiformis and gluten ataxia) and possibly immune-mediated (gluten sensitivity), and also outline pathogenic, clinical and epidemiological differences and propose new nomenclature and classifications.

It is now becoming apparent that reactions to gluten are not limited to CD, rather we now appreciate the existence of a spectrum of gluten-related disorders. The high frequency and wide range of adverse reactions to gluten raise the question as to why this dietary protein is toxic for so many individuals in the world. One possible explanation is that the selection of wheat varieties with higher gluten content has been a continuous process during the last 10,000 years, with changes dictated more by technological rather than nutritional reasons.

Additionally, gluten is one of the most abundant and diffusely spread dietary components for most populations, particularly those of European origin. In Europe, the mean consumption of gluten is 10 g to 20 g per day, with segments of the general population consuming as much as 50 g of daily gluten or more [6667] All individuals, even those with a low degree of risk, are therefore susceptible to some form of gluten reaction during their life span.

Ukjent sin avatar

Does gluten sensitivity in the absence of coeliac disease exist?

Artikkel som nevner den fremadstormende forskningen som gjøre på ikke-cøliakisk glutensensitivitet.

http://www.bmj.com/content/345/bmj.e7907

However, the number of patients consuming a gluten-free diet seems greatly out of proportion to the projected number of patients with coeliac disease. Marketers have estimated that 15-25% of North American consumers want gluten-free foods,4 5

A third of patients (n=276) showed clinical and statistically significant sensitivity to wheat and not placebo, with worsening abdominal pain, bloating, and stool consistency. The evidence therefore suggests that, even in the absence of coeliac disease, gluten based products can induce abdominal symptoms which may present as irritable bowel syndrome.

For patients who report wheat intolerance or gluten sensitivity, exclude coeliac disease (with endomysial and/or tissue transglutaminase antibodies and duodenal biopsies on a gluten containing diet) and wheat allergy (IgE serum assay or skin prick test to wheat). Those patients with negative results should be diagnosed with non-coeliac gluten sensitivity. These patients benefit symptomatically from a gluten-free diet. They should be told that non-coeliac gluten sensitivity is a newly recognised clinical entity for which we do not yet fully understand the natural course or pathophysiology.

Ukjent sin avatar

Inflammation and the pathophysiology of work-related musculoskeletal disorders

Viktig studie om betennelse og hvordan det påvirker muskler og annet vev i kroppen. Nevner gangen i prosessen: repetitiv muskelsammentrekning, økning i betennelsesfaktorer for å reprere, manglende restitusjon, økning i fibrøst vev (arrvev), kompresjon på nerver, myalgi, økt temperament, osv. Nevner også hvordan betennelser påvirker psyken; depresjon, nedsatt seksuallyst, tilbaketrekning, smerter, m.m. IL-6 gir utmattelse.

Den beskriver hvordan cytokiner sprøytet inn i mus gir «sickness behaviour» og hyperalgesi (økt smertesensitivitet). Studien her forholder seg mest til betennelser som følge av repetitive bevegelser, men dette utsagnet vil også tilsi at kosthold som øker pro-inflammatoriske cytokiner kan bidra til hyperalgesi.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1552097/

Results from several clinical and experimental studies indicate that tissue microtraumas occur as a consequence of performing repetitive and/or forceful tasks, and that this mechanical tissue injury leads to local and perhaps even systemic inflammation, followed by fibrotic and structural tissue changes.

We also propose a conceptual framework suggesting the potential roles that inflammation may play in these disorders, and how inflammation may contribute to pain, motor dysfunction, and to puzzling psychological symptoms that are often characteristic of patients with work-related MSDs.

Several recent clinical and experimental studies have been published indicating that inflammation plays a role in the development of tissue pathologies associated with these chronic disorders.

The US Department of Labor defines work-related MSDs as injuries or disorders of the muscles, nerves, tendons, joints, cartilage, and spinal discs associated with exposure to risk factors in the workplace. MSDs include sprains, strains, tears, back pain, soreness, pain, carpal tunnel syndrome, musculoskeletal system, or connective tissue diseases and disorders, when the event or exposure leading to the injury or illness is bodily reaction/bending, climbing, crawling, reaching, twisting; overexertion; or repetition (Bureau of Labor Statistics, 2005). Several risk factors are associated with the development or exacerbation of MSDs in the workplace, including physical, biomechanical, individual predisposition, and psychosocial conditions.

Psychosocial risk factors in the workplace also contribute to MSDs. These factors are associated with levels of workplace stress, such as job content and demands, job control, and social support (National Research Council, 2001). Non-workplace factors may also contribute to the development and exacerbation of MSDs, such as similar physical or high stress levels in the home. Certain past or present medical conditions also represent comorbid risk factors for MSDs (National Research Council, 2001).

Examples include past traumatic injury to the affected body part, systemic diseases that affect the musculoskeletal system, and diseases/disorders of the circulatory system. Women appear more susceptible than men to the development of MSDs, although this is highly industry-dependent. Advanced age or obesity may increase the impact of other risk factors on the severity of MSDs (National Research Council, 2001).

Musculotendinous injuries resulting from performing repetitive and/or forceful tasks are due to repeated overstretch, compression, friction, ischemia, and overexertion. We hypothesize that these injuries lead initially to an inflammatory response (Fig. 1). While the ultimate outcome of inflammation is to replace or repair injured tissues with healthy, regenerated tissue, Copstead and Banadki, 2000, when continued task performance is superimposed upon injured and inflamed tissue a vicious cycle of injury, chronic or systemic inflammation, fibrosis, and perhaps even tissue breakdown may occur. The end result is often pain and loss of motor function.


Schematic diagram showing three primary pathways hypothesized to lead to work-related musculoskeletal disorders caused by repetitive and/or forceful hand-intensive tasks: CNS reorganization (reviewed in Barr et al., 2004), tissue injury, or tissue reorganization.

Hirata et al. (2005) divided patients into symptom duration groups (<3, 4-7, 8-12, and >12 months).

  • Edematous changes were found in these tissues in patients of ❤ month duration.
  • Prostaglandin E2 (PGE2) and vascular endothelial growth factor (VEGF) were increased in patients of 4-7 month symptom duration,
  • while fibrotic changes were present in patients of longer symptom duration (>7 months).

PGE2 is a factor believed to cause vasodilation, edema, and enhancement of cytokines that induce synoviocyte proliferation, while VEGF is associated with endothelial and vascular smooth muscle cell proliferation during chronic inflammation. In Hirata’s study, both molecules peak in the intermediate phase (4-7 months) of CTS-induced tendosynovial changes and appear to contribute to tissue remodeling. Hirata postulates that since PGE2 is thought to regulate the production of several molecules, that it may regulate VEGF production in tenosynovium.

The increase in IL-6 is interesting. IL-6 has both inflammatory and anti-inflammatory properties, the latter primarily to suppress low-grade inflammation (Biffl et al., 1996). IL-6 is a tightly regulated cytokine normally not detectable in serum unless there is trauma, infection, or cellular stress, at which time IL-6 is an early cytokine responder. Pro-inflammatory effects of IL-6 include induction of cell growth and proliferation, and acute-phase responses, while its anti-inflammatory actions include inducing increases in serum IL-1 receptor antagonist and soluble TNF receptor (Biffl et al., 1996).

Trapezius muscle biopsies from male and female workers with either continuous or intermittent trapezius myalgia of at least 12 months duration show evidence of myopathic changes such as moth eaten and ragged, red type I muscle fibers, increased frequency of type II myofibers and atrophic myofibers consistent with muscle injury, and denervation/ischemic loss of muscle fibers, but no evidence of inflammation (Larsson et al., 2001). In contrast, Dennet and Fry (1988) examining the first dorsal interosseous muscle collected from 29 patients with painful chronic overuse syndrome found increased inflammatory cells as well as myopathic changes.

The first study, by Freeland et al. (2002) detected increased serum malondialdehyde, an indicator of cell stress, in patients with carpal tunnel syndrome, but no serum increases in PGE2, IL-1, or IL-6.

A recent study by Kuiper et al. (2005), examined serum for biomarkers of collagen synthesis and degradation (but not for biomarkers of injury or inflammation) in construction workers involved in heavy manual materials handling. Both collagen synthesis and degradation products were increased in workers involved in heavy manual tasks, although the overall ratio of synthesis to degradation products remained the same as in sedentary workers. Kuiper’s results suggest that tissues undergo adaptive growth responses that protect them from unresolved degradation.

In the third study, elevated plasma fibrinogen were present in subjects with low job control, linking perceived job stress with a biomarker of chronic inflammation (Clays et al., 2005).

a recently submitted study from our lab found increased pro-inflammatory cytokines in serum of patients with moderate and severe work-related MSD.

Archambault et al. (1997) observed hypercellularity, inflammatory cells, increased inflammatory cytokines, and increased mRNA of matrix molecules in the tendon by 6-8 weeks. When the kicking protocol was prolonged to 11 weeks, the inflammatory responses were apparently resolved. Instead, matrix reorganization processes, such as increased mRNA for collagen type III and matrix metalloproteinases, were observed (Archambault et al., 2001). Thus, in the higher demand kicking task, inflammation and tissue pathology were simultaneously present, while in the lower demand kicking task, inflammation preceeded matrix reorganization which may be a beneficial adaptive reorganization since no necrosis was observed.

In a series of studies, they report evidence of inflammation and angiogenesis (hypercellularity; increased COX-2 and VEGF mRNA) after 4 weeks of running at a rate of 17 m/min on a decline, 1 h/day for 5 days/week. These changes persisted through 16 weeks. They also found tendon thickening and reduced biomechanical tissue tolerance, changes that increased with continued exposure. Thus, repetitive tendon overuse is associated with inflammation. The tendon tissue is unable to launch a successful healing response due to continued use, and becomes fibrotic and structurally damaged.

These dose-dependent findings are similar to our recently submitted human study in which a systemic inflammatory mediator/marker response was greater in patients with moderate and severe MSD compared to mild.

In MSD, the primary causes of peripheral nerve trauma are over-stretch and compression of neuronal tissues during excursion (reviewed in Barr et al., 2004).

Animal models of chronic nerve constriction injury using ligatures show that chronic compression leads to an upregulation of intraneural inflammatory cytokines, fibrosis, Schwann cell death, axonal demyelination, and declines in electrophysiological function.
In our rat model, we found decreased nerve conduction velocity (NCV) in the median nerve at the wrist. By week 10 in HRLF rats, there was a small (9%) but significant decrease in NCV (Clark et al., 2003), demonstrating that nerve injury accumulates with continued task performance and leads to a clinically relevant loss of nerve function.

The association of motor behavioral changes with tissue changes in both our and Messner’s studies indicates that functional declines accompany tissue injury, inflammation and fibrosis/degeneration.

The psychoneuroimmunological effects of pro-inflammatory cytokines, specifically IL-1β, TNF-α, and IL-6, have been extensively studied in humans and in animal models over the past decade for their contribution to a constellation of physiological and behavioral responses known collectively as the “sickness behaviors”. This response includes fever, weakness, listlessness, hyperalgesia, allodynia, decreased social interaction and exploration, somnolence, decreased sexual activity, and decreased food and water intake (amply reviewed by Capuron and Dantzer, 2003Wieseler-Frank et al., 2005). Sickness behaviors can be induced by administration of exogenous cytokines to animals, whether the cytokines were injected peripherally or centrally. One mechanism of action, the immune-to-brain communication through activation of brain and spinal cord glial cells was reviewed by Wieseler-Frank et al. (2005). Activation of CNS glia and subsequent production of inflammatory cytokines can lead to hyperalgesia.

Cohen et al. (1997) have also speculated that the elevation of serum IL-6 produces fatigue, which then may be responsible for decreases in an individual’s ability to perform functionally. The possibility for patients with chronic inflammatory conditions to succumb to the depressive effects of local and systemic pro-inflammatory cytokines has implications in the management of overuse MSDs.

Symptoms of depression, anxiety, heightened job stress, more anger with their employer, higher pain ratings, greater reactivity to pain, enhanced feelings of being overwhelmed by pain, and low confidence in problem solving abilities have been reported in numerous epidemiological and clinical studies of patients with MSDs (Clays et al., 2005Gold et al., 2006Shaw et al., 2002).

We hypothesize that performance of repetitive and/or forceful tasks may induce MSDs through three primary pathways: (1) CNS reorganization, (2) tissue injury, and (3) tissue reorganization.

The extent of these changes is dependent on task exposure (duration and level). A systemic response may be stimulated by cytokines released into the blood stream by injured tissues and immune cells. Circulating cytokines can stimulate global responses such as widespread increase in macrophages, local and distant tissue sensitization, and perhaps the induction of sickness behaviors, depression or anxiety, as may cytokine elevation in peripheral nerve tissues.

Ukjent sin avatar

Carbon Dioxide Transport and Carbonic Anhydrase in Blood and Muscle

Viktig studie med alt om hvordan CO2 går fra celle til vev til blod og forholdet mellom bikarbonat og melkesyre.

http://m.physrev.physiology.org/content/80/2/681.full

One of the major requirements of the body is to eliminate CO2. The large, but highly variable, amount of CO2 that is produced within muscle cells has to leave the body finally via ventilation of the alveolar space. To get there, diffusion of CO2 has to occur from the intracellular space of muscles into the convective transport medium blood, and diffusion out of the blood has to take place into the lung gas space across the alveolocapillary barrier.

HCO3 −, and H+, are required for a great variety of other cellular functions such as secretion of acid or base and some reactions of intermediary metabolism. In exercising skeletal muscle, the other “end product” of metabolism, lactic acid, contributes huge amounts of H+and by these affects the predominance of the three forms of CO2, because HCO3 − as well as carbamate are critically dependent on the concentration of H+.

Discussion of the overall transport of CO2in skeletal muscle has to take into account this contribution of lactic acid and its involvement in kinetics and equilibria of CO2reactions.

Table 1.

CO2 transport in blood at rest and exercise

Arterial Rest Exercise
Venous v-a diff, mmol/l blood Venous v-a diff, mmol/l blood
mM mmol/l blood mM mmol/l blood mM mmol/l blood
Plasma
pH† 7.40 7.37 7.145*
PCO 2 40 46 78*
Dissolved 1.23 0.68 1.42 0.78 0.10 2.40 1.32 0.64
Bicarbonate 24.58 13.52 26.38 14.51 0.99 26.65* 14.66 1.14
Carbamate 0.54 0.30 0.55 0.30 0.01 0.44 0.24 −0.06
Sum plasma 26.35 14.49 28.35 15.59 1.10 29.49 16.22 1.72
Red blood cell
pH† 7.20 7.175 6.996
Hb, g/l 333
Hct† 0.45
HbO2, fract† 0.97 0.75 0.25
Dissolved 1.23 0.4 1.42 0.46 0.06 2.40 0.78 0.38
Bicarbonate 15.47 5.01 16.84 5.46 0.44 18.91 6.13 1.11
Carbamate 1.66 0.75 1.86 0.84 0.09 2.12 0.95 0.21
Sum RBC 18.37 6.16 20.12 6.75 0.59 23.43 7.86 1.70
Total CO2 20.65 22.34 1.69 24.08 3.42

1.  Dissolved CO2

Only a small portion, ∼5% of total arterial content, is present in the form of dissolved CO2.

At rest, the contribution of dissolved CO2 to the total arteriovenous CO2 concentration difference is only ∼10%. However, during heavy exercise, the contribution of dissolved CO2 can increase sevenfold and then makes up almost one-third of the total CO2 exchange.

2.  CO2 bound as HCO3−

The majority of CO2 in all compartments is bound as HCO3−.

During a heavy work load of the muscle, high levels of lactic acid are present in addition to CO2, aggravating the decrease in pH. With this low pH, the fraction of HCO3− in total CO2 is diminished. Although at pH 7.4 HCO3− is 20-fold compared with dissolved CO2, it is only 13-fold at the normal intraerythrocytic pH of 7.2, and the ratio may fall to much lower values at plasma pH values of considerably below 7 during maximal exercise.

For the example of heavy exercise given in Table 1, HCO3 −contributes only two-thirds of total CO2 exchange, whereas at rest this figure is ∼85%.

3.  CO2 bound as carbamate

The amount of CO2 bound as carbamate to hemoglobin in erythrocytes or to plasma proteins depends on O2 saturation of hemoglobin and 2,3-diphosphoglycerate (2,3-DPG) concentration in the case of erythrocytes, and on H+concentration in the case of both red blood cells and plasma (61, 68, 134, 135). During passage of blood through muscle, O2 saturation and H+ concentration change considerably, in particular during exercise. However, the increase in hemoglobin desaturation and the increase in H+ concentration experienced by red blood cells in the capillary during exercise affect the amount of CO2bound to hemoglobin in opposite directions. Whereas deoxygenation of hemoglobin increases the amount of CO2 bound to hemoglobin, acidification decreases the amount of carbamate formed by hemoglobin.

Carbamate concentration in plasma does not contribute to overall CO2 exchange according to Table 1, which is in agreement with Klocke’s conclusion (105). During heavy exercise, arterial plasma contains an even higher concentration of carbamate than venous plasma. The physicochemical reason for this is that, in the absence of an oxylabile carbamate fraction as exhibited by hemoglobin, the increase in carbamate by the elevated PCO 2in venous plasma is counteracted or overruled by a decrease in carbamate caused by the fall in pH.


Fig. 2.

Diffusion constants of CO2 (in cm2·min−1·atm−1) at 22°C in different tissues as a function of the protein concentration (points) and in hemoglobin solutions of different hemoglobin concentrations (solid line). [Redrawn from Gros and Moll (64).]

2.  Diffusion of HCO3−

The diffusion coefficients for HCO3− are about one-half as great as those for CO2, and in the presence of proteins, its diffusion can be expected to be hindered to an extent comparable to that observed for CO2 diffusion.

Therefore, the HCO3− concentration gradient per CO2concentration gradient is higher at low PCO 2, and vice versa. This implies that the relative contribution of facilitated diffusion is highest at lowest PCO 2values and decreases consistently with increasing PCO 2 (66, 67).

3.  Diffusion of H+

The diffusion coefficient of free H+ in aqueous solutions at 25°C is 9.3 × 10−5 cm2/s (123), i.e., H+ possess a more than five times greater diffusivity in water than CO2. Nevertheless, free diffusion of H+ is a rather ineffective mechanism of H+ transport, because at physiological values of pH, the H+ concentration gradients within cells cannot exceed the order of 10−7 to 10−8 M.

This very much higher concentration difference of the bound H+ compensates for the lower diffusion coefficients of mobile buffers.

In the case of very large protein molecules, it has even been shown that facilitated H+ transport occurs very efficiently not only by translational but in addition by rotational protein diffusion (62, 63). Thus facilitated CO2 diffusion essentially occurs by diffusion of HCO3− and simultaneous buffer-facilitated H+ diffusion.

Fig. 3.

Calculated CO2 fluxes across a layer of buffer solution as a function of the average pH value in this layer. The boundary CO2partial pressures are constant with 6.65 and 5.32 kPa (50 and 40 mmHg), respectively. The solution is 66 mM phosphate with varying contents of base. Thickness of the layer is 180 μm. Carbonic anhydrase is assumed to be present in excess. Solid curve represents the total flux of CO2, and dashed curve represents the flux by free diffusion only. [Redrawn from Gros et al. (67).]

1.  Dissolved CO2

Erythrocyte membranes, though, are highly permeable to CO2, the absolute permeability values cited being in the range of 0.35–3 cm/s (Table 3), as has been thoroughly discussed by Klocke (105).

2.  HCO3−

Permeability for HCO3− of artificial phospholipid vesicles, which are devoid of any anion exchanger, is six orders of magnitude lower (Table 3; Ref. 127) than it is for dissolved CO2. However, erythrocyte membranes of all vertebrates with the exception of agnathans (hagfishes and lampreys; see reviews, Refs. 80, 126, 136) do have a rapid anion (HCO3−/Cl−) exchange protein, capnophorin or band 3 (see review by Jennings, Ref. 90), which exchanges HCO3− for Cl− at a ratio of 1:1.

Thus the permeability of the erythrocyte membrane to HCO3− is considerably increased over that of lipid bilayers but still about three to four orders of magnitude lower than the permeability for dissolved CO2 (Table 3).

3.  H+

Proton permeability of phospholipid vesicles is five times higher than HCO3− permeability, 1.8 × 10−5cm/s (127). However, because the H+concentration gradient across the cell membrane is very small (intracellular pH 7.2, extracellular pH 7.4, ΔpH 0.2), the product permeability × concentration gradient, is also very small:P H+ × cH+ = 1.8 × 10−5 cm/s × 2.3 × 10−8 M = 4 × 10−13 mmol H+·cm−2·s−1. Thus diffusion of free H+ across the membrane is so small that it cannot support any facilitated CO2 diffusion.

A third mechanism of H+ transport across the red cell membrane is by the H+/lactate carrier and by nonionic diffusion of lactic acid, both of which require the presence of lactate (27, 138).

Thus, in the presence of lactate, the above H+ flux estimate would have to be raised to ∼4 × 10−9mmol·cm−2· s−1, which is much lower than the flux estimate for HCO3−. The fluxes of both ions, however, are more than two orders of magnitude smaller than a physiological CO2 flux.

In conclusion, the permeability of dissolved CO2 is much greater than the effective permeability of HCO3− and H+. At the same time, more than two-thirds of the CO2 transported in either red blood cells or plasma is transported in the form of HCO3−. This makes it appear essential that CO2 and HCO3− can be converted into each other quite rapidly at the boundary between the two compartments: intraerythrocytic space and plasma. A high velocity of this interconversion is achieved by the enzyme CA.

Although HCO3− and H+ are produced in equal amounts by the hydration of CO2, the distribution of the two products among the two compartments, intraerythrocytic space and plasma, is quite different at electrochemical equilibrium. Bicarbonate is transported to a larger fraction within plasma than within erythrocytes because the equilibrium pH of the plasma is more alkaline than the intraerythrocytic pH (Table 1). In contrast, H+ are transported to a larger fraction within erythrocytes than in plasma because the nonbicarbonate buffer capacity of erythrocytes exceeds that of plasma by a factor of ∼10.

A) RAPID CATALYSIS OCCURS ONLY WITHIN ERYTHROCYTES. Carbon dioxide enters the red blood cells, and there is rapidly converted to HCO3− and H+. When the red blood cell has reached the end of the capillary, electrochemical equilibrium across erythrocyte membrane is not yet established, because H+concentration and even more so HCO3− concentration are too high within red blood cells compared with plasma concentrations. A significant fraction of the intraerythrocytic HCO3−has left the cell via HCO3−/Cl− exchange already during capillary transit. After blood has left the capillary, part of HCO3− and H+ that has been produced within the red blood cell is dehydrated back to give CO2; CO2 then leaves the cell and enters the plasma, where the slow uncatalyzed reaction hydrates CO2 to establish final equilibrium. During this postcapillary process, the plasma pH shifts slowly in the acidic direction.

1.  Catalysis by CA in blood

Carbonic anhydrase is found in the blood of all vertebrates.

The acceleration of the hydration-dehydration velocity by CA within erythrocytes is considerable. An activity (factor by which the rate of CO2 hydration is accelerated) of 13–14,000 was reported by Forster and Itada (46), and figures of 23,000 and 25,000 have been obtained by Wistrand (184) and by Forster et al. (47).

membrane-bound CA IV was found to be associated with capillary endothelium, sarcolemma, and sarcoplasmic reticulum (SR) (24).

The effect of presence of CA in the plasma has been studied by Wood and Munger (186) for the rainbow trout. They found that CA attenuated postexercise increases in PCO 2 and decreases in arterial pH by producing an increase in CO2excretion during exercise. However, the normal postexercise hyperventilation was also greatly attenuated when CA was present in the plasma, as was the normal increase in the plasma levels of epinephrine and norepinephrine. They concluded that CO2 is an important secondary drive to ventilation in fish, and by increasing CO2 excretion by the presence of CA in the plasma this drive is diminished. The plasma CA inhibitor will ensure that no CA activity of hemolysed erythrocytes is present and thus will contribute to maintain a high level of ventilation in certain situations, which will be favorable for O2 supply.

A.  CO2 Production in Muscle

Unlike most other tissues, muscle exhibits a vast range of aerobic (and anaerobic) metabolic rates. In humans, O2 consumption of muscle tissue can rise 15- to 20-fold from resting values of ∼10 μmol·min−1·100 g−1, and even higher increases have been reported from 6.3 mmol·min−1·100 g−1 at rest to 200 μmol·min−1·100 g−1 at maximal exercise of a small muscle group (forearm; Ref. 73). Carbon dioxide production rates can be calculated from these O2 consumption rates using a RQ of ∼0.85. The PCO 2 values in the venous blood leaving the skeletal muscle have also been measured and are ∼5.32–5.99 kPa (40–45 mmHg) at rest and can rise to as much as ∼13.3 kPa (100 mmHg) during exercise (for example, Ref. 95).

Although different muscle types and different mammalian species have vastly different maximal specific O2 consumption rates, maximal specific mitochondrial O2 consumption differs considerably less. At maximum O2 consumption (VO 2max), mitochondria of different species consumed 4.56 ± 0.61 ml O2·min−1·ml−1(87). This indicates that it is essentially mitochondrial density in muscle fibers that determines maximal specific O2 consumption of these fibers.

In heavily exercising muscle, in addition to CO2, lactic acid is produced and the additional H+ shift the equilibrium of the hydration/dehydration reaction toward CO2 and have to be buffered and eliminated from the cell. Intracellular pH of skeletal muscle can become very low and can decrease from ∼7.2 at rest to a value as low as 6.6–6.7 (6, 110) or to even lower values of 6.2–6.4 (119,152, 183) during maximal exercise. Accordingly, during maximal work, HCO3 −concentration is only two times that of dissolved CO2, whereas during rest, the ratio of HCO3 −/CO2 is ∼13. As a result, less facilitation of CO2 diffusion can be expected to take place during heavy exercise. At the same time, the “CO2store” in the muscle, HCO3 −, will be mobilized by the intracellular metabolic acidosis producing high PCO 2 values in muscle tissue and in the venous blood leaving the exercising muscle.

The intracellular H+ transport capacity, which suffices to transport H+ at a rate equal to the rate of HCO3− transport as it results from a HCO3 − concentration difference in the millimolar range (facilitated CO2 diffusion), will also suffice to transport H+ at a rate equaling the lactate flux that results from a lactate concentration difference in the millimolar range (lactic acid transport). Thus lactic acid, which is almost completely dissociated at physiological pH values, can be efficiently transported through the cell interior utilizing this facilitated H+ transport system. It may be noted that this H+ transport system under conditions of exclusively aerobic metabolism is used by the cell to maintain a facilitation of CO2 diffusion, whereas under conditions of dominating anaerobic glycolysis and low intracellular pH, it is mainly used to transport H+ along with the lactate anion through the intracellular space, a prerequisite for the elimination of lactic acid from the cell.


Fig. 4.

Schematic representation of proposed role of sarcoplasmic reticulum (SR) carbonic anhydrase (CA) in Ca2+ transport across the SR membrane. Catalyzed CO2 hydration within the SR provides protons that are exchanged for Ca2+ across SR membrane. Ca2+ uptake requires rapid H+ production within SR, as shown; Ca2+ release requires rapid H+buffering. Other counterions of Ca2+ appear to be Mg2+ and K+. As indicated at right, scheme on left is projected into a cross section through SR or L system. [From Geers et al. (55).]

During the capillary transit, the blood takes up CO2, H+, and lactate from the muscle cell via the interstitial space. Chemical and transport events that occur during gas and lactic acid exchange, which we have included in our calculations, are with few exceptions shown in Figure 6. With steady-state conditions, it is assumed that within each part of the interstitial space along the capillary wall concentrations are constant. Thus the sum of influx and efflux into this compartment and the rate of change of chemical rection has to be zero for CO2, HCO3 −, H+, and lactate.

The reactions and transport events included in the analysis are described as follows.

For CO2,

1) hydration/dehydration reaction catalyzed by CA or uncatalyzed;

2) diffusion between skeletal muscle cell, interstitial space, and erythrocytes; and

3) binding of CO2 to hemoglobin within erythrocytes (not shown in Fig. 6).

For HCO3 −, hydration/dehydration reaction catalyzed by CA or not (see point 1);

4) diffusion from interstitial space into plasma, and vice versa; and

5) movement between plasma and erythrocytes via anion exchanger.

For H+, hydration/dehydration reaction catalyzed by CA or not (see point 1);

6) buffered by proteins inside erythrocytes and plasma (not shown in Fig. 6);

7) cotransport of H+ and lactate ions across the sarcolemmal and red cell membrane;

8) release of H+by carbamate reaction (not shown in Fig. 6);

9) uptake of H+due to deoxygenation of hemoglobin (not shown in Fig. 6); and

10) diffusion across the capillary wall.

For lactate, cotransport of H+ and lactate ions across the sarcolemma and erythrocytes (see point 7);

11) movement of lactate ions via anion exchanger between plasma and erythrocytes.

An increase of the intramuscular partial pressure of CO2 to values as high as 13.3 kPa (100 mmHg) does not require any higher CA activity inside erythrocytes.

The same holds for a higher HCO3 − permeability of the erythrocyte membrane: when the HCO3 − permeability is assumed to be three times higher than the standard value used, the arteriovenous differences are unaltered compared with those seen in Figure 8. This implies that no additional CA would be necessary if the permeability of the erythrocyte membrane for HCO3 − were higher. (It may be noted that massive reduction of HCO3 −permeability per se decreases CO2 excretion in the lung, Ref. 23).

In other words, neither does the HCO3 −permeability of the red cell membrane set a limit to CO2uptake, nor does red cell CA activity ever become limiting at increased levels of CO2production. A possible situation where intraerythrocytic CA may become more critical, which has to our knowledge never been investigated, is a severe lactic acidosis with low intraerythrocytic pH values. At a pH of 6.4, the activity of CA II decreases to ∼30% of its value at pH 7.2 (99), and in this situation, more enzyme will be necessary to maintain the required activity.

More H+ arrive in the blood, and pH in plasma and in red blood cells decreases. This implies that, at a given PCO 2(here 55 mmHg), the total CO2 bound in the blood is reduced, because both HCO3 − and carbamate decrease with decreasing pH. Thus lactic acidosis decreases the total CO2release from muscle into blood at a given PCO 2. Because CO2 production continues, the consequence is a rise in tissue and venous blood PCO 2 values. For the whole body, heavy exercise therefore is associated with rather high muscle venous PCO 2 values and, as is well known, part of this CO2 is mobilized by lactic acid from the CO2 stores in muscle and blood.

Ukjent sin avatar

Bench-to-bedside review: Carbon dioxide

Om CO2 i helbredelse av vev. Viktig oversikt som nevner CO2 sin bane og effekt gjennom hele organismen – fra DNA til celle til vev til blod. Bekrefter ALT jeg har funnet om CO2 og pusteknikkene. Nevner også potensiell farer, som kun skjer ved akutt hypercapnia. Nevner også en meget spennende konsept om å buffre CO2 acidose med bikarbonat (Natron). I kliniske tilfeller på sykehus kan det ha negative effekter, men hos normale mennesker vil det virke som en effektiv buffer.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887152/

Hypercapnia may play a beneficial role in the pathogenesis of inflammation and tissue injury, but may hinder the host response to sepsis and reduce repair. In contrast, hypocapnia may be a pathogenic entity in the setting of critical illness.

For practical purposes, PaCO2 reflects the rate of CO2 elimination.

The commonest reason for hypercapnia in ventilated patients is a reduced tidal volume (VT); this situation is termed permissive hypercapnia.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887152/table/T1/?report=previmg

High VT causes, or potentiates, lung injury [4]. Smaller VT often leads to elevated PaCO2, termed permissive hypercapnia, and is associated with better survival [5,6]. These low-VT strategies are not confined to patients with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS); they were first reported successful in severe asthma [7], and attest to the overall safety of hypercapnia. Indeed, hypercapnia in the presence of higher VT may independently improve survival [8].

Hypocapnia is common in several diseases (Table ​(Table1;1; for example, early asthma, high-altitude pulmonary edema, lung injury), is a common acid-base disturbance and a criterion for systemic inflammatory response syndrome [9], and is a prognostic marker of adverse outcome in diabetic ketoacidosis [10]. Hypocapnia – often prolonged – remains common in the management of adult [11] and pediatric [12] acute brain injury.

Table 1

Causes of hypocapnia

Hypoxemia Altitude, pulmonary disease
Pulmonary disorders Pneumonia, interstitial pneumonitis, fibrosis, edema, pulmonary emboli, vascular disease, bronchial asthma, pneumothorax
Cardiovascular system disorders Congestive heart failure, hypotension
Metabolic disorders Acidosis (diabetic, renal, lactic), hepatic failure
Central nervous system disorders Psychogenic/anxiety hyperventilation, central nervous system infection, central nervous system tumors
Drug induced Salicylates, methylxanthines, β-adrenergic agonists, progesterone
Miscellaneous Fever, sepsis, pain, pregnancy

CO2 is carried in the blood as HCO3-, in combination with hemoglobin and plasma proteins, and in solution. Inside the cell, CO2 interacts with H2O to produce carbonic acid (H2CO3), which is in equilibrium with H+ and HCO3-, a reaction catalyzed by carbonic anhydrase. CO2 transport into cells is complex, and passive diffusion, specific transporters and rhesus proteins may all be involved.

CO2 is sensed in central and peripheral neurons. Changes in CO2 and H+ are sensed in chemosensitive neurons in the carotid body and in the hindbrain [13,14]. Whether CO2 or the pH are preferentially sensed is unclear, but the ventilatory response to hypercapnic acidosis (HCA) exceeds that of an equivalent degree of metabolic acidosis [15], suggesting specific CO2 sensing.

An in vitro study has demonstrated that elevated CO2 levels suppress expression of TNF and other cytokines by pulmonary artery endothelial cells via suppression of NF-κB activation [18].

Furthermore, hypercapnia inhibits pulmonary epithelial wound repair also via an NF-κB mechanism [19].

The physiologic effects of CO2 are diverse and incompletely understood, with direct effects often counterbalanced by indirect effects.

Hypocapnia can worsen ventilation-perfusion matching and gas exchange in the lung via a number of mechanisms, including bronchoconstriction [21], reduction in collateral ventilation [22], reduction in parenchymal compliance [23], and attenuation of hypoxic pulmonary vasoconstriction and increased intrapulmonary shunting [24].

CO2 stimulates ventilation (see above). Peripheral chemoreceptors respond more rapidly than the central neurons, but central chemosensors make a larger contribution to stimulating ventilation. CO2increases cerebral blood flow (CBF) by 1 to 2 ml/100 g/minute per 1 mmHg in PaCO2[25], an effect mediated by pH rather than by the partial pressure of CO2.

Hypercapnia elevates both the partial pressure of O2 in the blood and CBF, and reducing PaCO2 to 20 to 25 mmHg decreases CBF by 40 to 50% [26]. The effect of CO2 on CBF is far larger than its effect on the cerebral blood volume. During sustained hypocapnia, CBF recovers to within 10% baseline by 4 hours; and because lowered HCO3-returns the pH towards normal, abrupt normalization of CO2 results in (net) alkalemia and risks rebound hyperemia.

Hypocapnia increases both neuronal excitability and excitatory (glutamatergic) synaptic transmission, and suppresses GABA-A-mediated inhibition, resulting in increased O2 consumption and uncoupling of metabolism to CBF [27].

Hypercapnia directly inhibits cardiac and vascular muscle contractility, effects that are counterbalanced by sympathoadrenal increases in heart rate and contractility, increasing the cardiac output overall [28].

Indeed, a large body of evidence now attests to the ability of hypercapnia to increase peripheral tissue oxygenation, independently of its effects on cardiac output [30,31].

The beneficial effects of HCA in such models are increasingly well understood, and include attenuation of lung neutrophil recruitment, pulmonary and systemic cytokine concentrations, cell apoptosis, and O2-derived and nitrogen-derived free radical injury.

Concern has been raised regarding the potential for the anti-inflammatory effects of HCA to impair the host response to infection. In early pulmonary infection, this potential impairment does not appear to occur, with HCA reducing the severity of acute-severe Escherichia coli pneumonia-induced ALI [41]. In the setting of more established E. coli pneumonia, HCA is also protective [42].

Hypocapnia increases microvascular permeability and impairs alveolar fluid reabsorption in the isolated rat lung, due to an associated decrease in Na/K-ATPase activity [47].

HCA protects the heart following ischemia-reperfusion injury.

Hypercapnia attenuates hypoxic-ischemic brain injury in the immature rat [52] and protects the porcine brain from reoxygenation injury by attenuation of free radical action. Hypercapnia increases the size of the region at risk of infarction in experimental acute focal ischemia; in hypoxic-ischemic injury in the immature rat brain, hypocapnia worsens the histologic magnitude of stroke [52] and is associated with a decrease in CBF to the hypoxia-injured brain as well as disturbance of glucose utilization and phosphate reserves.

Indeed, hypocapnia may be directly neurotoxic, through increased incorporation of choline into membrane phospholipids [56].

Rapid induction of hypercapnia in the critically ill patient may have adverse effects. Acute hypercapnia impairs myocardial function.

In patients managed with protective ventilation strategies, buffering of the acidosis induced by hypercapnia remains a common – albeit controversial – clinical practice.
While bicarbonate may correct the arterial pH, it may worsen an intracellular acidosis because the CO2 produced when bicarbonate reacts with metabolic acids diffuses readily across cell membranes, whereas bicarbonate cannot.

Hypocapnia is an underappreciated phenomenon in the critically ill patient, and is potentially deleterious, particularly when severe or prolonged. Hypocapnia should be avoided except in specific clinical situations; when induced, hypercapnic acidosis should be for specific indications while definitive measures are undertaken.

Ukjent sin avatar

Hypercapnia Induces Cleavage and Nuclear Localization of RelB Protein, Giving Insight into CO2 Sensing and Signaling

Viktig studie om CO2 som betennelsesdempende, og den fremtredende rolle i moderne forskning, og hvordan kroppen og cellene bruker det som signalstoff. Nevner at det demper betennelse ved å dempe pro-inflammatoriske genuttrykk.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340129/

Carbon dioxide (CO2) is increasingly being appreciated as an intracellular signaling molecule that affects inflammatory and immune responses.

In patients suffering from this syndrome (COPD), therapeutic hypoventilation strategy designed to reduce mechanical damage to the lungs is accompanied by systemic hypercapnia and associated acidosis, which are associated with improved patient outcome.

Recently, a role for the non-canonical NF-κB pathway has been postulated to be important in signaling the cellular transcriptional response to CO2. (Om NF-kB her: http://en.wikipedia.org/wiki/NF-κB)

Taken together, these data demonstrate that RelB is a CO2-sensitive NF-κB family member that may contribute to the beneficial effects of hypercapnia in inflammatory diseases of the lung.

The physiologic gas nitric oxide (NO) is sensed by cells and profoundly impacts upon intracellular signaling pathways through altering the activity of enzymes, including guanylate cyclase and cytochrome c oxidase (1,2). Furthermore molecular oxygen, another physiologic gas, is also sensed by cells and elicits signaling responses through altering hydroxylase activity, leading to activation of the hypoxia-inducible factor (HIF) (3). Carbon dioxide (CO2), a product of oxidative metabolism, is another physiologic gas with a recently appreciated role in the suppression of proinflammatory transcriptional pathways (4).

Patients in respiratory distress who are placed on ventilators have intentionally lowered tidal and minute volumes to protect the lungs against mechanical damage (810). This leads to an increase in paCO2. This protective ventilation strategy is termed “permissive hypercapnia.” In addition to reducing ventilator-associated lung injury, permissive hypercapnia has been demonstrated to decrease mortality in acute respiratory distress syndrome patients (11,12).

The NF-κB family of transcription factors is responsible for the regulation of innate immune, inflammatory, and anti-apoptotic gene expression. We have previously demonstrated a link between hypercapnia and NF-κB signaling (15). Elevated CO2 leads to a less inflammatory phenotype via the suppression of NF-κB-dependent proinflammatory gene expression (10).

In this study, we demonstrate that under conditions of elevated CO2, RelB is cleaved to a low molecular weight form that translocates to the nucleus, where it impacts upon the expression of proinflammatory genes. We dissected the relative contribution of CO2 and pH to RelB processing and inflammatory gene expression. Furthermore, we investigated the requirement of RelB for the suppression of specific inflammatory gene expression under conditions of elevated CO2. Finally, we provide mechanistic insight into RelB processing in response to CO2.

Taken together, these studies indicate that CO2 is a physiologic regulator of inflammatory gene expression and that non-canonical NF-κB family members are key to mediating the anti-inflammatory effects of CO2.

Arterial levels of CO2 can range from ~25 mm Hg (~3.6%) to >100 mm Hg (~13%) in pathophysiologic states. To determine the range of sensitivity of RelB to CO2, we exposed MEFs to 2% or 10% CO2 for 1 h before re-equilibration to 0.03% CO2 conditions for 5 min in each case. We observed a dose-dependent nuclear accumulation of RelB at 2% CO2, which was significantly more pronounced at 10% CO2 (Fig. 2A). Furthermore, return to ambient CO2 levels resulted in a rapid reversal of nuclear RelB localization (Fig. 2A), confirming that the impact of elevated CO2 on RelB is both rapid and reversible.

Hypercapnia is usually accompanied by acidosis in vivo. This is because CO2 forms carbonic acid in solution, leading to a cellular microenvironment that is both hypercapnic and acidic.

Leukocyte nuclear RelB staining in lungs from LPS-treated rats was significantly increased in the 5% CO2 group compared with the 0% CO2 group (Fig. 3, B and C). This enhanced nuclear RelB staining in the therapeutic hypercapnic acidosis group is associated with better survival, improved lung function, and a significant degree of lung protection as a consequence of reduced inflammatory damage (28). These data provide further supportive evidence for RelB nuclear localization under conditions of hypercapnia both in vivo and in vitro and demonstrate a correlation between nuclear RelB expression and improved disease outcome.

Under both neutral and acidic conditions, elevated CO2 suppressed TNFα to the same degree (Fig. 4A), indicating that the effects of elevated CO2 on inflammatory gene expression are independent of alterations in pHe. Thus, exposure to hypercapnia suppresses TNFα-stimulated inflammatory gene expression. Consistent with our previous studies (15), buffering pHe to a neutral value did not affect the suppressive effects of elevated CO2.

In summary, elevated CO2 suppresses cytokine-stimulated inflammatory gene expression, and this suppression is modestly enhanced in cells in which RelB expression is suppressed. Although the specific mechanism remains to be determined, these data support a role for RelB in the regulation of inflammatory gene expression under conditions of hypercapnia.

Hypercapnia is defined as the situation that arises when blood pCO2 is higher than normal. It is associated with a range of diseases, including chronic obstructive pulmonary disease, and is a clinically tolerated consequence of a low tidal volume ventilation strategy for acute respiratory distress syndrome (6). Low tidal volume ventilation strategies have come to prominence given the significant decrease in patient mortality seen with this approach compared with the traditional ventilation strategy in a large multicenter trial (12).

RelB is an NF-κB family member that, along with p52, forms the characteristic dimer of the non-canonical pathway. Knockdown of RelB has previously been demonstrated to impair cellular immunity and to lead to multi-organ inflammation (20), suggesting an anti-inflammatory role for RelB. In addition, RelB acts downstream of signaling molecules previously shown to be involved in CO2signaling.

In summary, we have identified a novel signaling event in which RelB becomes cleaved and localizes to the nucleus under conditions of hypercapnia and hypercapnic acidosis in vitro and is associated with improved outcome in an in vivo model of LPS-induced lung injury. Hypercapnia can influence ligand-induced NF-κB target gene expression independently of pHe. Hypercapnia-dependent RelB processing and localization are sensitive to MG-132 but do not involve GSK3β or MALT-1, as has been described in other models (23). Taken together, they provide new mechanistic insight into the molecular mechanisms underpinning CO2 signaling, with significant implications for clinical medicine.

Ukjent sin avatar

CO2 Reduction to Formate by NADH Catalysed by Formate Dehydrogenase from Pseudomonas oxalaticus

Nevner hvordan CO2 inngår direkte i Krebs syklus og NADH. Hele studien finnes som pdf i denne linken.

http://onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.1976.tb11021.x/full

Proof for this reaction is supplied by the detection of a CO2-dependent NADH oxidation, and by the identification of [14C]carbonate.

That CO2 and not HCO3 is the active species in the reduction was shown by comparing the pH dependency of the velocities of the forward and back reactions and by observing the kinetics of CO2 reduction during the simultaneous attainment of the CO2-HCO−3 equilibrium.

Ukjent sin avatar

Somatosensory Demands Modulate Muscular Beta Oscillations, Independent of Motor Demands

Om at berørelse og bevegelse er det samme i hjernen og helt ned på muskelnivå. Og at berørelse demper signaler fra musklene i hjernen. Trenger hele denne studien.

http://www.jneurosci.org/content/33/26/10849.short?rss=1

Specifically, somatosensory demands suppress the degree to which not only cortical activity but also muscular activity oscillates in the beta band. This suppression of muscular beta oscillations by perceptual demands is specific to demands in the somatosensory modality and occurs independent of movement preparation and execution: it occurs even when no movement is required at all.

This places touch perception as an important computation within this widely distributed somatomotor beta network and suggests that, at least in healthy subjects, somatosensation and action should not be considered as separable processes, not even at the level of the muscles.